Announcement

Commerce & Finance Law Offices (“Tongshang”), together with Eric Chow & Co., its Hong Kong associated law firm (“Tongshang Hong Kong”), jointly represented Immunotech Biopharm Ltd (“Immunotech Biopharm”) in its listing on the Main Board of the Hong Kong Stock Exchange (HKSE: 06978.HK) on 10 July 2020. The Hong Kong Public Offering was very well received by the investors and recorded approximately 259 times oversubscription. Immunotech Biopharm’s listing is yet another project collaborated and completed by Tongshang Beijing and Tongshang Hong Kong, in which we proudly provided a “one-stop shop” PRC and Hong Kong legal services to our client.

Immunotech Biopharm is a leading cellular immunotherapy biopharmaceutical company in China focusing on the research, development, and commercialisation of T cell immunotherapy over 13 years. According to the Frost & Sullivan Report, EAL® - Immunotech Biopharm's Core Product Candidate is the first cellular immunotherapy product in China approved for entry into a Phase II clinical trial, and, the only that had been approved for application in a Phase II clinical trial for solid tumour.

Tongshang and Tongshang Hong Kong acted as the issuer’s PRC and Hong Kong legal adviser in this Hong Kong IPO respectively and have provided high-quality and tailor-made legal solutions to the issuer throughout the listing process.

Tongshang has been renowned for its experiences in Biotech and Healthcare sector and Immunotech Biopharm is another Hong Kong biotech listing successfully completed by Tongshang, previous experiences include Ascletis Pharma, Hua Medicine, Innovent Biologics, CanSino Biologics, Mabpharm Limited, Sinomab Bioscience, Alphamab Oncology, Innocare Pharma, Akeso and Peijia Medical.

Tongshang tops the chart of PRC Legal Advisers in Biotech sector in 2020 by completing four Hong Kong IPOs for pre-revenue biotech companies so far, namely, Innocare Pharma, Akeso, Peijia Medical and Immunotech. In another milestone, Tongshang Hong Kong is also the first Hong Kong associated law firm of a PRC firm to successfully complete a Hong Kong listing under Chapter 18A of the Hong Kong Listing Rules.

The successful listing of Immunotech Biopharm has demonstrated the professionalism, extensive experience and great collaboration between Tongshang’s China and Hong Kong teams. Tongshang always strive to maintain a very good relationship with their clients and provide the best legal services to them. In order to provide clients with a comprehensive and “one-stop shop” PRC and Hong Kong legal services, Tongshang Hong Kong office was set up. The expansion into the Hong Kong legal market has enabled us to provide a full legal service on advising both Hong Kong and PRC laws in IPOs and other capital markets transactions.

Eric Chow & Co. in Association with Commerce & Finance Law Offices (“Tongshang Hong Kong”) represented Maike Tube Industry Holdings Limited (“Maike Tube”) in its listing on the Main Board of the Hong Kong Stock Exchange (HKSE: 01553.HK) on 18 December 2019. Maike Tube also marked the first manufacturing company in Jinan that is listed in Hong Kong.

Maike Tube is principally engaged in manufacturing and selling of standard pre-fabricated pipe nipple products and steel pipe products. It also designs and supplies a range of assembled piping systems to its customers. Maike Tube operates two production plants in Jinan and a production plant in Dong Nai Province, Vietnam. Maike Tube’s customers are based in Mainland China and more than 35 countries overseas. According to Frost & Sullivan Report, it ranked first in the PRC standard prefabricated pipe nipple industry in terms of export value by tons in 2018.

Tongshang Hong Kong acted as the Hong Kong legal adviser of the IPO of Maike Tube and has provided high-quality and tailor-made legal solutionsto the issuer throughout the listing process.

The successful listing of Maike Tube has demonstrated the professionalism and extensive experience of our team. Commerce & Finance Law Offices always strive to maintain a very good relationship with their clients and provide the best legal services to them. In order to provide clients with a comprehensive and “one-stop shop” PRC and Hong Kong legal services, the Tongshang Hong Kong office was set up. The expansion into the Hong Kong legal market has enabled us to provide a full legal service on advising both Hong Kong and PRC laws in IPOs and other capital markets transactions.

On February 21, 2019, Commerce & Finance Law Offices (“C&F”) had its office Opening Ceremony to officially launch its new Hong Kong office, which is in association with local firm Eric Chow & Co.

Over 450 distinguished guests and industry leaders, including the representatives from the Liaison Office of the Central People's Government in the HKSAR, Director-General of Investment Promotion of InvestHK of The Government of HKSAR, a representative from Hong Kong's Department of Justice and long-term and valued clients, attended the office opening cocktail reception along with C&F's partners from Beijing, Shanghai, Shenzhen and Hong Kong offices.

The launching ceremony started with Mr. Stephen Phillips, Director-General of Investment Promotion of InvestHK, who extended his warm welcome on behalf of The Government of HKSAR and wished us every success in our future endeavours. Mr. Han Xiaojing, one of the founders of C&F, expressed his sincere gratitude towards fellow professional parties in the Hong Kong capital markets who have provided C&F with support and assistance throughout the years. Mr. Han Xiaojing expressed confidence that through the establishment of C&F's Hong Kong office, C&F will be able to provide a “one-stop shop” of Mainland Chinese and Hong Kong legal services to our clients.

Mr. Eric Chow, Managing Partner of C&F's Hong Kong office, gave a brief introduction on the main practice areas, credentials and the near-future plans for the Hong Kong office. Mr. Chow also expressed his gratitude to the clients, intermediaries and friends for their support. He also expressed that with the advantage of serving as “四地一家” (“Four Lands One Family”), C&F's Hong Kong office will be able to provide our valued clients with a wider scope of first-class legal services.

Subsequently, Mr. Han Xiaojing, Mr. Eric Chow, partners from the C&F Management Committee, representatives from the Liaison Office the Central People's Government in the HKSAR, and Director-General of Investment Promotion of InvestHK, commenced the traditional act of “dotting” the dragon-dance lions' eyes before the lion dance performance which represented C&F's motto of “Four Lands One Family”.

Throughout the past 27 years since its establishment in 1992, C&F has always adhered to the principle of professional integrity and excellence and strived to provide its clients with pragmatic and cost-effective legal solutions that meet their best interests. C&F first established its branch offices in Shanghai and Shenzhen and now with the establishment of its Hong Kong office, C&F can provide its clients and partners' with “one-stop shop” cross-border legal services between Mainland China and Hong Kong.

C&F's Hong Kong office is led by a number of professional lawyers with extensive experience from international leading law firms and a former senior officer with over 20 years of experience at the Hong Kong Stock Exchange. C&F's Hong Kong office's main practice areas include capital markets, regulatory compliance, M&A and other corporate services. For more information, please visit www.tongshang.com.

On this occasion, C&F would like to sincerely thank all the distinguished guests and business leaders for attending the office opening cocktail reception, as well as the eminent clients and partners who have always supported C&F in expanding its business.